pharmaceutical and biological preparations utilizing aCT1 peptide to restore Connexin43 protein junction integrity in cells, namely, ophthalmic eye drops useful in treating corneal injuries or ocular injury due to chemical agents, dermatological topical formulations useful in treating cutaneous radiation injuries, cutaneous scarring, and thermal burns, and inhalation solutions useful in treating acute lung injuries